RAFFERTY ASSET MANAGEMENT, LLC – Apellis Pharmaceuticals, Inc. Transaction History
RAFFERTY ASSET MANAGEMENT, LLC portfolio value:
$7.00M
portfolio value
RAFFERTY ASSET MANAGEMENT, LLC quarter portfolio value change:
+51.04%
quarter
Apellis Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +10.42% | 9.68K shares | 2.80M | $68.3 | 102.57K |
| Q2 2022 | share | Decrease | -24.78% | -30.60K shares | -2.07M | $45.22 | 92.88K |
| Q1 2022 | share | Decrease | -1.92% | -2.41K shares | 322K | $50.81 | 123.49K |
| Q4 2021 | share | Increase | +41.16% | 36.71K shares | 3.01M | $47.95 | 125.91K |
| Q3 2021 | share | Increase | +112.42% | 47.20K shares | 286K | $32.96 | 89.19K |
| Q2 2021 | share | Decrease | -41.20% | -29.42K shares | -410K | $63.2 | 41.99K |
| Q1 2021 | share | Increase | +280.68% | 52.65K shares | 1.99M | $42.91 | 71.41K |
| Q4 2020 | share | Decrease | -72.90% | -50.47K shares | -1.01M | $57.2 | 18.75K |
| Q3 2020 | share | Increase | +124.63% | 38.41K shares | 1.08M | $30.17 | 69.22K |
| Q2 2020 | share | Increase | +273.02% | 22.55K shares | 786K | $32.66 | 30.81K |
| Q1 2020 | share | Decrease | -88.24% | -61.99K shares | -1.93M | $26.79 | 8.26K |
| Q4 2019 | share | Increase | +17.73% | 10.57K shares | 713K | $30.62 | 70.25K |
| Q3 2019 | share | Decrease | -7.91% | -5.12K shares | -204K | $24.09 | 59.67K |
| Q2 2019 | share | Increase | +136.91% | 37.45K shares | 1.10M | $25.34 | 64.80K |
| Q1 2019 | share | Increase | 0.00% | 27.35K shares | 533K | $19.5 | 27.35K |